20 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
responsibility for the risk management process, including monitoring and assessing strategic risk exposure, its Committees oversee risk in certain … and avoiding litigation abuse resulting from the current disparity that exists in the treatment of directors, who oversee and are ultimately accountable
8-K
EX-1.1
LRMR
Larimar Therapeutics Inc
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
(“Exchange Rules”), validly appointed an audit committee to oversee internal accounting controls whose composition satisfies the applicable requirements
8-K
EX-1.1
sdklb5svsby
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
8-K
EX-10.2
xaks73n3vejuewvyye
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.3
7isi5vp120 yauti7d9
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.2
v0k3rabprucai
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
qdrn9gdcmm8sc7 bi
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
5ll0448utufly1cjtp0
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
ci6il6kvjin 2d
6 Mar 20
Preliminary proxy related to merger
5:32pm
- Prev
- 1
- Next